PCDH10

Across TCGA pan-cancer cohorts, PCDH10 mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated PCDH10 data layer compared with 22 for mass-spec protein and 8 for mutation status.

The strongest signal is observed in glioblastoma multiforme (GBM), where higher PCDH10 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated PCDH10 expression acts as an unfavorable survival marker, although some lineages such as GBM and LSCC show a favorable association.

GBM and LSCC are the cancer types where PCDH10 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
GBM	DFS	Median	All	0.852	0.637	.001	15	view →
LSCC	DFS	Quartile	II,III,IV	0.917	0.443	.014	11	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

PCDH10–GBM (DFS)

Open the GBM breakdown →